3 employees
EternaTear is developing a next-generation therapy for the over-the-counter dry eye market.
2018
$4.9M
from 6 investors over 6 rounds
EternaTear raised $4.9M on October 11, 2020
Investors: Carolina Angel Network, FAN Fund, Keiretsu Capital, Band of Angels, Duke Angel Network and Keiretsu Forum / Capital